$EGAN
EGAIN Corp

2024 Q2 Form 10-Q Financial Statement

#000155837024007595 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $22.46M $22.35M
YoY Change -8.82% -2.88%
Cost Of Revenue $6.906M $6.858M
YoY Change 3.29% -9.7%
Gross Profit $15.56M $15.49M
YoY Change -13.33% 0.48%
Gross Profit Margin 69.25% 69.32%
Selling, General & Admin $7.685M $7.899M
YoY Change -14.99% -14.54%
% of Gross Profit 49.4% 50.99%
Research & Development $6.679M $6.655M
YoY Change 1.95% -0.48%
% of Gross Profit 42.94% 42.96%
Depreciation & Amortization $91.00K $92.00K
YoY Change -17.27% -25.81%
% of Gross Profit 0.58% 0.59%
Operating Expenses $14.36M $14.55M
YoY Change -7.87% -8.64%
Operating Profit $1.192M $938.0K
YoY Change -49.45% -283.2%
Interest Expense $865.0K $1.002M
YoY Change 12.63% 22.49%
% of Operating Profit 72.57% 106.82%
Other Income/Expense, Net -$38.00K $74.00K
YoY Change -91.63% -130.2%
Pretax Income $2.019M $2.014M
YoY Change -24.44% 3201.64%
Income Tax $513.0K $521.0K
% Of Pretax Income 25.41% 25.87%
Net Earnings $1.506M $1.493M
YoY Change -42.1% -501.34%
Net Earnings / Revenue 6.7% 6.68%
Basic Earnings Per Share $0.05 $0.05
Diluted Earnings Per Share $0.05 $0.05
COMMON SHARES
Basic Shares Outstanding 29.83M 31.20M
Diluted Shares Outstanding 31.60M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.00M $82.98M
YoY Change -4.37% 2.06%
Cash & Equivalents $70.00M $82.98M
Short-Term Investments
Other Short-Term Assets $5.390M $1.317M
YoY Change 325.08% 21.61%
Inventory
Prepaid Expenses $2.915M $2.387M
Receivables $31.73M $10.95M
Other Receivables $0.00 $0.00
Total Short-Term Assets $107.1M $98.89M
YoY Change -2.46% 2.39%
LONG-TERM ASSETS
Property, Plant & Equipment $4.252M $483.0K
YoY Change 571.72% -28.55%
Goodwill $13.19M $13.19M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.290M $1.954M
YoY Change 142.8% 68.89%
Total Long-Term Assets $20.73M $21.43M
YoY Change 2.16% 3.72%
TOTAL ASSETS
Total Short-Term Assets $107.1M $98.89M
Total Long-Term Assets $20.73M $21.43M
Total Assets $127.9M $120.3M
YoY Change -1.74% 2.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.725M $1.534M
YoY Change 33.32% 2.61%
Accrued Expenses $13.90M $5.615M
YoY Change 158.01% 2.0%
Deferred Revenue $45.99M $34.34M
YoY Change -3.71% -2.18%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $62.61M $49.62M
YoY Change -1.74% -1.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.743M $887.0K
YoY Change 706.58% 8.44%
Total Long-Term Liabilities $6.743M $887.0K
YoY Change 706.58% 8.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $62.61M $49.62M
Total Long-Term Liabilities $6.743M $887.0K
Total Liabilities $69.36M $56.46M
YoY Change 1.37% 1.9%
SHAREHOLDERS EQUITY
Retained Earnings -$323.7M -$325.2M
YoY Change -2.35% -2.66%
Common Stock $407.4M $405.6M
YoY Change 1.58% 1.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.50M $63.86M
YoY Change
Total Liabilities & Shareholders Equity $127.9M $120.3M
YoY Change -1.74% 2.62%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $1.506M $1.493M
YoY Change -42.1% -501.34%
Depreciation, Depletion And Amortization $91.00K $92.00K
YoY Change -17.27% -25.81%
Cash From Operating Activities -$5.120M $1.748M
YoY Change 14.8% 93.15%
INVESTING ACTIVITIES
Capital Expenditures $49.00K $14.00K
YoY Change -30.0% -118.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$49.00K -$14.00K
YoY Change -30.0% -118.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.929M -5.354M
YoY Change 93.86% 436.47%
NET CHANGE
Cash From Operating Activities -5.120M 1.748M
Cash From Investing Activities -49.00K -14.00K
Cash From Financing Activities -7.929M -5.354M
Net Change In Cash -13.10M -3.620M
YoY Change 51.95% 20011.11%
FREE CASH FLOW
Cash From Operating Activities -$5.120M $1.748M
Capital Expenditures $49.00K $14.00K
Free Cash Flow -$5.169M $1.734M
YoY Change 14.11% 76.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Entity Central Index Key
EntityCentralIndexKey
0001066194
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35314
dei Entity Registrant Name
EntityRegistrantName
eGain Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0466366
dei Entity Address Address Line1
EntityAddressAddressLine1
1252 Borregas Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Sunnyvale
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94089
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
636-4500
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
EGAN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29826703
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82982000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73201000
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
209000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
237000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10950000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31569000
CY2024Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1247000
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1317000
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2387000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2466000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1317000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1268000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
98890000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
109828000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
483000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
633000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4077000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2797000
CY2024Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1734000
CY2023Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
2318000
CY2024Q1 us-gaap Goodwill
Goodwill
13186000
CY2023Q2 us-gaap Goodwill
Goodwill
13186000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1954000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1355000
CY2024Q1 us-gaap Assets
Assets
120324000
CY2023Q2 us-gaap Assets
Assets
130117000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1534000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2044000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6933000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7697000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5615000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5387000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1192000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
832000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
34342000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
47762000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
49616000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
63722000
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3157000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2101000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2803000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1762000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
887000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
836000
CY2024Q1 us-gaap Liabilities
Liabilities
56463000
CY2023Q2 us-gaap Liabilities
Liabilities
68421000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32523000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32268000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30382000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31482000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
33000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
32000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
405590000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
401087000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2141000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
786000
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
14292000
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
5763000
CY2024Q1 egan Notes Receivable From Stockholders
NotesReceivableFromStockholders
21000
CY2023Q2 egan Notes Receivable From Stockholders
NotesReceivableFromStockholders
97000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2282000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2122000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-325167000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-331441000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
63861000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
61696000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120324000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130117000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22350000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23013000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70341000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73376000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6858000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7595000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20686000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20629000
CY2024Q1 us-gaap Gross Profit
GrossProfit
15492000
CY2023Q1 us-gaap Gross Profit
GrossProfit
15418000
us-gaap Gross Profit
GrossProfit
49655000
us-gaap Gross Profit
GrossProfit
52747000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6655000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6687000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19947000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20749000
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5448000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6837000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16901000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
25191000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2451000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2406000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8028000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7776000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
14554000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
15930000
us-gaap Operating Expenses
OperatingExpenses
44876000
us-gaap Operating Expenses
OperatingExpenses
53716000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
938000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-512000
us-gaap Operating Income Loss
OperatingIncomeLoss
4779000
us-gaap Operating Income Loss
OperatingIncomeLoss
-969000
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1002000
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
818000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2933000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1633000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
74000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-245000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2014000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
61000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7699000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
684000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
521000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
433000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1425000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1176000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1493000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-372000
us-gaap Net Income Loss
NetIncomeLoss
6274000
us-gaap Net Income Loss
NetIncomeLoss
-492000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30976000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32122000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31212000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32024000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31599000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32122000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31858000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32024000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1493000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-372000
us-gaap Net Income Loss
NetIncomeLoss
6274000
us-gaap Net Income Loss
NetIncomeLoss
-492000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-181000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
392000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-160000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
186000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1312000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6114000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-306000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
66793000
CY2024Q1 egan Paid In Kind Interest On Stockholder Loan
PaidInKindInterestOnStockholderLoan
-1000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
161000
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5514000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1110000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-181000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1493000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
63861000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
61371000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
103000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1101000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1447000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
392000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-372000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
61840000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
61696000
egan Paid In Kind Interest On Stockholder Loan
PaidInKindInterestOnStockholderLoan
-1000
us-gaap Repayments Of Debt
RepaymentsOfDebt
77000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
574000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
417000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8529000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3513000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-160000
us-gaap Net Income Loss
NetIncomeLoss
6274000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
63861000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
56857000
egan Paid In Kind Interest On Stockholder Loan
PaidInKindInterestOnStockholderLoan
-1000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
568000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
540000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1101000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5283000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
186000
us-gaap Net Income Loss
NetIncomeLoss
-492000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
61840000
us-gaap Profit Loss
ProfitLoss
6274000
us-gaap Profit Loss
ProfitLoss
-492000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1170000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1151000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
829000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
845000
egan Depreciation And Amortization Of Capital Lease Assets
DepreciationAndAmortizationOfCapitalLeaseAssets
296000
egan Depreciation And Amortization Of Capital Lease Assets
DepreciationAndAmortizationOfCapitalLeaseAssets
375000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
99000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
182000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
464000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
363000
us-gaap Share Based Compensation
ShareBasedCompensation
3513000
us-gaap Share Based Compensation
ShareBasedCompensation
5283000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
9000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20505000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16702000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
522000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
415000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-75000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
54000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
201000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
139000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-47000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-508000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-215000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-754000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1334000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
233000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
564000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-12328000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-12273000
egan Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-709000
egan Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-790000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
58000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
19000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17574000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9080000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
149000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
218000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-149000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-218000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
574000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
568000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
417000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
540000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8529000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1101000
egan Interest On Notes Receivable Due From Stockholders Financing Activities
InterestOnNotesReceivableDueFromStockholdersFinancingActivities
1000
egan Proceeds From Repayment Of Notes Receivable Due From Stockholders
ProceedsFromRepaymentOfNotesReceivableDueFromStockholders
77000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7462000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-182000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
264000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9781000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9133000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73208000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72180000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82989000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81313000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1165000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1591000
egan Operating Lease Operating Lease Liability Increase Decrease Due To Lease Modification
OperatingLeaseOperatingLeaseLiabilityIncreaseDecreaseDueToLeaseModification
2140000
egan Operating Lease Operating Lease Liability Increase Decrease Due To Lease Modification
OperatingLeaseOperatingLeaseLiabilityIncreaseDecreaseDueToLeaseModification
91000
egan Revenue Payment Term Maximum
RevenuePaymentTermMaximum
P45D
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Organization and Nature of Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">eGain Corporation (eGain, the Company, our, we or us) automates customer engagement with an innovative knowledge hub, powered by conversational artificial intelligence (AI) and analytics. We sell mostly to large enterprises across financial services, telecommunications, retail, government, healthcare, and utilities seeking to better serve customers at scale while coping with content silos, process complexity, and regulatory compliance. With our mantra of <b style="font-weight:bold;">AX + BX + CX = DX™</b>, we guide clients to effortless digital experience (DX) by holistically optimizing agent experience (AX), business experience (BX), and customer experience (CX). Leading brands use eGain’s cloud software to improve customer satisfaction, empower agents, reduce service cost, and boost sales. We are headquartered in the United States. We also operate in the United Kingdom and India.</p>
us-gaap Fiscal Period
FiscalPeriod
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Fiscal Year</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company fiscal year ends on June 30. References to fiscal year 2024 refers to fiscal year ending June 30, 2024.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The preparation of financial statements requires us to make estimates and assumptions in the condensed consolidated financial statements and accompanying notes. Actual results could differ significantly from estimates. We make estimates that we believe to be reasonable based on historical experience and other assumptions. Significant estimates and assumptions made by management include the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Standalone selling price (SSP) of performance obligations for contracts with multiple performance obligations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Estimate of variable consideration for performance obligations in connection with Topic 606;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Period of benefit associated with capitalized costs to obtain revenue contracts;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Valuation, measurement and recognition of current and deferred income taxes;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Fair value of stock-based awards; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Lease term and incremental borrowing rate for lease liabilities.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
egan Number Of Revenue Categories
NumberOfRevenueCategories
2
egan Revenue Payment Term Minimum
RevenuePaymentTermMinimum
P30D
CY2024Q1 egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
36000
egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
522000
CY2024Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
325000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1200000
CY2023Q1 egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
6000
egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
415000
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
381000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1200000
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3000000.0
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3600000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
egan Number Of Operating Regions
NumberOfOperatingRegions
3
CY2023Q1 egan Number Of Operating Regions
NumberOfOperatingRegions
3
egan Number Of Operating Regions
NumberOfOperatingRegions
3
CY2024Q1 egan Number Of Operating Regions
NumberOfOperatingRegions
3
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
938000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-512000
us-gaap Operating Income Loss
OperatingIncomeLoss
4779000
us-gaap Operating Income Loss
OperatingIncomeLoss
-969000
CY2024Q1 us-gaap Noncurrent Assets
NoncurrentAssets
483000
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
633000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Concentration of Credit Risk and Significant Customers </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our financial instruments that are exposed to concentrations of credit risk include cash and cash equivalents, restricted cash, and accounts receivable. We complement direct sales with resell partnerships based on product connectors into cloud contact center platforms. We also partner with system integrators and managed service providers. Two customers, who are also partners, accounted for more than 10% of total revenue during the three and nine months ended March 31, 2024. One of such partners accounted for more than 10% of total revenue during the three and nine months ended March 31, 2023. Two customers accounted for more than 10% of our gross accounts receivable balance as of March 31, 2024.</p>
egan Number Of Customers And Partners That Accounted For More Than Ten Percentage Of Revenue
NumberOfCustomersAndPartnersThatAccountedForMoreThanTenPercentageOfRevenue
2
CY2024Q1 egan Number Of Customers And Partners That Accounted For More Than Ten Percentage Of Revenue
NumberOfCustomersAndPartnersThatAccountedForMoreThanTenPercentageOfRevenue
2
egan Number Of Partners Accounted For More Than Ten Percentage Of Revenue
NumberOfPartnersAccountedForMoreThanTenPercentageOfRevenue
1
CY2023Q1 egan Number Of Partners Accounted For More Than Ten Percentage Of Revenue
NumberOfPartnersAccountedForMoreThanTenPercentageOfRevenue
1
CY2024Q1 egan Number Of Customers That Accounted For More Than Ten Percent Of Companys Accounts Receivable
NumberOfCustomersThatAccountedForMoreThanTenPercentOfCompanysAccountsReceivable
2
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1110000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1447000
us-gaap Share Based Compensation
ShareBasedCompensation
3513000
us-gaap Share Based Compensation
ShareBasedCompensation
5283000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23013000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70341000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73376000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22350000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23013000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70341000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73376000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22350000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23013000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70341000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73376000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22350000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
34342000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
47762000
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3157000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2101000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
37499000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
49863000
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8200000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
31600000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
67700000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
47900000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
19800000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1493000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-372000
us-gaap Net Income Loss
NetIncomeLoss
6274000
us-gaap Net Income Loss
NetIncomeLoss
-492000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30976000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32122000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31212000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32024000
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
623000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
646000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31599000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32122000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31858000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32024000
egan Number Of Operating Leases Modified
NumberOfOperatingLeasesModified
3
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2100000
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
353000
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
325000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1000000.0
us-gaap Operating Lease Expense
OperatingLeaseExpense
961000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
310000
us-gaap Operating Lease Payments
OperatingLeasePayments
900000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
307000
us-gaap Operating Lease Payments
OperatingLeasePayments
900000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4077000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2797000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1192000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
832000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2803000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1762000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y4M2D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0761
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0497
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
299000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1181000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1056000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
805000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
278000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
278000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1249000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5146000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1151000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3995000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1192000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2803000
egan Warranty Period Maximum
WarrantyPeriodMaximum
P1Y
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
5700000
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
880569
CY2024Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
6.26
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5500000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1354467
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
6.30
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8500000
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
egan-20240331_cal.xml Edgar Link unprocessable
0001558370-24-007595-index-headers.html Edgar Link pending
0001558370-24-007595-index.html Edgar Link pending
0001558370-24-007595.txt Edgar Link pending
0001558370-24-007595-xbrl.zip Edgar Link pending
egan-20240331.xsd Edgar Link pending
egan-20240331x10q.htm Edgar Link pending
egan-20240331xex31d1.htm Edgar Link pending
egan-20240331xex31d2.htm Edgar Link pending
egan-20240331xex32d1.htm Edgar Link pending
egan-20240331xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
egan-20240331_def.xml Edgar Link unprocessable
egan-20240331_lab.xml Edgar Link unprocessable
egan-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
egan-20240331x10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending